Currently holds positions in La Jolla Pharmaceutical Co, Odonate Therapeutics Inc and Heron Therapeutics Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | La Jolla Pharmaceutical Co | Aug. 1, 2014 - |
Chairman of the Board, Chief Executive Officer | Odonate Therapeutics Inc | Jan. 1, 2013 - |
Independent Chairman of the Board | Heron Therapeutics Inc | July 30, 2012 - |
Independent Director | Heron Therapeutics Inc | Feb. 8, 2009 - July 30, 2012 |
Independent Director | Ardea Biosciences Inc | May 1, 2003 - June 19, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-18 | 2023-12-18 |
Rain Therapeutics Inc
(RAIN)
|
S Sale |
40,132
-1.0%
1.2148,560 USD |
40,132 -1.0% | 1.21 | 48,560 USD | |
2023-12-18 | 2023-12-15 |
Rain Therapeutics Inc
(RAIN)
|
S Sale |
109,435
-2.7%
1.20131,322 USD |
109,435 -2.7% | 1.20 | 131,322 USD | |
2023-12-18 | 2023-12-14 |
Rain Therapeutics Inc
(RAIN)
|
S Sale |
24,406
-0.6%
1.2129,531 USD |
24,406 -0.6% | 1.21 | 29,531 USD | |
2023-10-13 | 2023-10-13 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
84,145
+2.1%
0.9983,304 USD |
84,145 +2.1% | 0.99 | 83,304 USD | |
2023-10-13 | 2023-10-13 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
47,486
+1.2%
0.9947,011 USD |
47,486 +1.2% | 0.99 | 47,011 USD | |
2023-10-13 | 2023-10-12 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
52,514
+1.4%
0.9851,464 USD |
52,514 +1.4% | 0.98 | 51,464 USD | |
2023-10-13 | 2023-10-12 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
25,188
+0.7%
0.9824,684 USD |
25,188 +0.7% | 0.98 | 24,684 USD | |
2023-10-13 | 2023-10-11 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
74,812
+2.0%
0.9772,568 USD |
74,812 +2.0% | 0.97 | 72,568 USD | |
2023-06-01 | 2023-06-01 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
240,341
+6.9%
1.12269,182 USD |
240,341 +6.9% | 1.12 | 269,182 USD | |
2023-06-01 | 2023-06-01 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
92,984
+2.7%
1.09101,353 USD |
92,984 +2.7% | 1.09 | 101,353 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
2,016
+0.1%
1.082,177 USD |
2,016 +0.1% | 1.08 | 2,177 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
32,890
+1.0%
1.0634,863 USD |
32,890 +1.0% | 1.06 | 34,863 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
200,000
+6.7%
1.00200,000 USD |
200,000 +6.7% | 1.00 | 200,000 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
B Purchase |
347,932
+13.1%
1.05365,329 USD |
347,932 +13.1% | 1.05 | 365,329 USD | |
2023-05-30 | 2023-05-25 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
50,000
+1.2%
1.7286,000 USD |
50,000 +1.2% | 1.72 | 86,000 USD | |
2023-05-15 | 2023-05-12 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
6,183
+0.1%
1.9512,057 USD |
6,183 +0.1% | 1.95 | 12,057 USD | |
2023-05-15 | 2023-05-11 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
38,765
+0.9%
1.9575,592 USD |
38,765 +0.9% | 1.95 | 75,592 USD | |
2023-05-10 | 2023-05-10 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
6,774
+0.2%
1.9513,209 USD |
6,774 +0.2% | 1.95 | 13,209 USD | |
2023-05-10 | 2023-05-09 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
20,141
+0.5%
1.9539,275 USD |
20,141 +0.5% | 1.95 | 39,275 USD | |
2023-05-10 | 2023-05-08 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
57,073
+1.4%
1.95111,292 USD |
57,073 +1.4% | 1.95 | 111,292 USD | |
2023-05-05 | 2023-05-05 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
71,064
+1.7%
1.94137,864 USD |
71,064 +1.7% | 1.94 | 137,864 USD | |
2023-05-05 | 2023-05-05 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
95,759
+2.4%
1.90181,942 USD |
95,759 +2.4% | 1.90 | 181,942 USD | |
2023-05-05 | 2023-05-04 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
104,241
+2.6%
1.86193,888 USD |
104,241 +2.6% | 1.86 | 193,888 USD | |
2023-05-05 | 2023-05-03 |
TCR2 Therapeutics Inc
(TCRR)
|
B Purchase |
18,513
+0.5%
1.8534,249 USD |
18,513 +0.5% | 1.85 | 34,249 USD | |
2023-03-14 | 2023-03-14 |
Jounce Therapeutics Inc
(JNCE)
|
B Purchase |
20,286
+0.4%
1.0220,651 USD |
20,286 +0.4% | 1.02 | 20,651 USD | |
2023-03-14 | 2023-03-13 |
Jounce Therapeutics Inc
(JNCE)
|
B Purchase |
65,701
+1.3%
0.9965,307 USD |
65,701 +1.3% | 0.99 | 65,307 USD | |
2021-12-01 | 2021-12-01 |
La Jolla Pharmaceutical Co
(LJPC)
|
S Sale |
41,290
-0.4%
3.66151,303 USD |
41,290 -0.4% | 3.66 | 151,303 USD | |
2021-12-01 | 2021-12-01 |
La Jolla Pharmaceutical Co
(LJPC)
|
S Sale |
136,255
-1.4%
3.76512,128 USD |
136,255 -1.4% | 3.76 | 512,128 USD | |
2021-12-01 | 2021-11-30 |
La Jolla Pharmaceutical Co
(LJPC)
|
S Sale |
63,745
-0.6%
3.95251,544 USD |
63,745 -0.6% | 3.95 | 251,544 USD | |
2021-12-01 | 2021-11-30 |
La Jolla Pharmaceutical Co
(LJPC)
|
S Sale |
6,597
-0.1%
3.9526,067 USD |
6,597 -0.1% | 3.95 | 26,067 USD | |
2021-12-01 | 2021-11-29 |
La Jolla Pharmaceutical Co
(LJPC)
|
S Sale |
193,403
-1.9%
4.10793,107 USD |
193,403 -1.9% | 4.10 | 793,107 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
160,000
-100.0%
9.601,536,560 USD |
160,000 -100.0% | 9.60 | 1,536,560 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
200,000
-55.6%
10.072,014,440 USD |
200,000 -55.6% | 10.07 | 2,014,440 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
50,889
-12.4%
10.43530,665 USD |
50,889 -12.4% | 10.43 | 530,665 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
149,111
-26.6%
11.191,668,433 USD |
149,111 -26.6% | 11.19 | 1,668,433 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
75,491
-11.9%
11.74886,430 USD |
75,491 -11.9% | 11.74 | 886,430 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
124,509
-16.4%
12.451,550,187 USD |
124,509 -16.4% | 12.45 | 1,550,187 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
161,336
-17.5%
13.522,181,521 USD |
161,336 -17.5% | 13.52 | 2,181,521 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
38,664
-4.0%
6.55253,373 USD |
38,664 -4.0% | 6.55 | 253,373 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
3,719
-0.4%
6.6624,779 USD |
3,719 -0.4% | 6.66 | 24,779 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
196,281
-16.9%
7.111,395,185 USD |
196,281 -16.9% | 7.11 | 1,395,185 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
16,667
-1.4%
7.36122,651 USD |
16,667 -1.4% | 7.36 | 122,651 USD | |
2021-11-22 | 2021-11-19 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
183,333
-13.5%
7.521,378,756 USD |
183,333 -13.5% | 7.52 | 1,378,756 USD | |
2021-11-22 | 2021-11-19 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
30,467
-2.2%
8.01244,111 USD |
30,467 -2.2% | 8.01 | 244,111 USD | |
2021-11-19 | 2021-11-19 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
365,289
-2.8%
1.92699,930 USD |
365,289 -2.8% | 1.92 | 699,930 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
169,533
-10.9%
8.091,372,319 USD |
169,533 -10.9% | 8.09 | 1,372,319 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
4,023
-0.3%
8.0032,190 USD |
4,023 -0.3% | 8.00 | 32,190 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
152,764
-8.9%
8.321,271,516 USD |
152,764 -8.9% | 8.32 | 1,271,516 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
S Sale |
43,213
-2.5%
9.38405,532 USD |
43,213 -2.5% | 9.38 | 405,532 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
381,842
-2.8%
1.89722,636 USD |
381,842 -2.8% | 1.89 | 722,636 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
500,000
-3.6%
1.88940,600 USD |
500,000 -3.6% | 1.88 | 940,600 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
212,423
-1.5%
1.97418,643 USD |
212,423 -1.5% | 1.97 | 418,643 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
287,577
-2.0%
2.20632,238 USD |
287,577 -2.0% | 2.20 | 632,238 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
500,000
-3.3%
2.021,008,050 USD |
500,000 -3.3% | 2.02 | 1,008,050 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
31,151
-0.2%
1.9962,118 USD |
31,151 -0.2% | 1.99 | 62,118 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
S Sale |
468,849
-3.0%
2.661,246,341 USD |
468,849 -3.0% | 2.66 | 1,246,341 USD | |
2021-05-26 | 2021-05-26 |
La Jolla Pharmaceutical Co
(LJPC)
|
B Purchase |
166,932
+1.7%
4.26710,763 USD |
166,932 +1.7% | 4.26 | 710,763 USD | |
2021-05-26 | 2021-05-25 |
La Jolla Pharmaceutical Co
(LJPC)
|
B Purchase |
31,782
+0.3%
3.83121,874 USD |
31,782 +0.3% | 3.83 | 121,874 USD | |
2021-05-26 | 2021-05-25 |
La Jolla Pharmaceutical Co
(LJPC)
|
B Purchase |
95,597
+1.0%
3.77360,860 USD |
95,597 +1.0% | 3.77 | 360,860 USD | |
2021-05-26 | 2021-05-24 |
La Jolla Pharmaceutical Co
(LJPC)
|
B Purchase |
104,403
+1.1%
3.68384,234 USD |
104,403 +1.1% | 3.68 | 384,234 USD | |
2020-12-23 | 2020-12-23 |
Odonate Therapeutics Inc
(ODT)
|
B Purchase |
75,784
+0.5%
15.711,190,415 USD |
75,784 +0.5% | 15.71 | 1,190,415 USD | |
2020-12-23 | 2020-12-23 |
Odonate Therapeutics Inc
(ODT)
|
B Purchase |
63,354
+0.4%
15.43977,438 USD |
63,354 +0.4% | 15.43 | 977,438 USD | |
2020-12-23 | 2020-12-22 |
Odonate Therapeutics Inc
(ODT)
|
B Purchase |
36,646
+0.2%
15.17555,821 USD |
36,646 +0.2% | 15.17 | 555,821 USD | |
2020-12-23 | 2020-12-22 |
Odonate Therapeutics Inc
(ODT)
|
B Purchase |
37,856
+0.2%
14.58551,766 USD |
37,856 +0.2% | 14.58 | 551,766 USD | |
2020-12-23 | 2020-12-21 |
Odonate Therapeutics Inc
(ODT)
|
B Purchase |
62,144
+0.4%
14.58905,767 USD |
62,144 +0.4% | 14.58 | 905,767 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
2,650
+0.2%
23.8763,256 USD |
2,650 +0.2% | 23.87 | 63,256 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
107,901
+6.5%
23.482,533,515 USD |
107,901 +6.5% | 23.48 | 2,533,515 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
29,682
+1.8%
22.33662,799 USD |
29,682 +1.8% | 22.33 | 662,799 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
34,044
+2.1%
20.63702,328 USD |
34,044 +2.1% | 20.63 | 702,328 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
8,482
+0.5%
20.94177,613 USD |
8,482 +0.5% | 20.94 | 177,613 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
137,241
+9.5%
20.782,851,868 USD |
137,241 +9.5% | 20.78 | 2,851,868 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
171,626
+13.5%
23.794,082,983 USD |
171,626 +13.5% | 23.79 | 4,082,983 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
71,241
+6.0%
15.321,091,412 USD |
71,241 +6.0% | 15.32 | 1,091,412 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
77,133
+6.9%
14.221,096,831 USD |
77,133 +6.9% | 14.22 | 1,096,831 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
B Purchase |
160,000
+16.7%
15.312,449,600 USD |
160,000 +16.7% | 15.31 | 2,449,600 USD |